Caxton Associates
Caxton Associates LP is a $7.6 billion New York-based hedge fund, founded in 1983 by Bruce Kovner.
Caxton Associates' primary business is to manage client and proprietary capital through global macro hedge fund strategies as well as other alternative investment disciplines.
Caxton employs over 205 people at its offices in New York, Princeton, NJ and London.
View Older Stories View More Recent Stories
-
Synta Pharmaceuticals (SNTA) CEO Steps Up with Buy Post 70% Collapse
-
Caxton Associates Raises Stake in US Airways Group, Inc. (LCC) to 5.39%
-
Big Hedge Funds are Moving Cash into Housing... Really??
-
Caxton Global Announces Departure of Two Co-Founders, Kovner & D’Angelo
-
Caxton Investment's Chairman, CEO Kovner, Pres D'Angelo to retire; Andrew Law named as successor to Kovner
-
Synta Pharma (SNTA) Completes 1.44M Common Sale to Board Member
-
Sunesis Pharma (SNSS) Closes $28.5M Private Placement
-
The Top 25 Hedge Fund Managers For 2008
-
Quarterly Data Confirms Hedge Funds Exited Stocks In A Big Way
-
October Hammers Several Hedge Funds
-
Caxton Associates Raises Stake in Ferro (FOE) to 5.2%
-
Caxton Associates Accumulates 5.1% Stake in Tercica (TRCA)
-
Caxton Associates Accumulates 5.5% Stake in Innophos Holdings (IPHS)
-
Caxton Associates Discloses 5.8% Stake in BladeLogic (BLOG)
-
Kovner's Caxton Associates Boosts Stake in Stewart Enterprises (STEI) to 6.6%
-
Caxton Associates Discloses 6.1% Stake in CollaGenex (CGPI)
-
Kovner's Caxton Associates Boosts Stake in Rural Cellular (RCCC) to 6.1%

